* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 659 | BMPR2 | C0034091 | Pulmonary Veno-Occlusive Disease (disorder) | 0.600549453568426 | BEFREE;CTD_human;HPO;ORPHANET |
| 659 | BMPR2 | C3203102 | Idiopathic pulmonary arterial hypertension | 0.515989208731916 | BEFREE;HPO;MGD;UNIPROT |
| 659 | BMPR2 | C0020542 | Pulmonary Hypertension | 0.433572558393424 | CTD_human;GAD;HPO;LHGDN |
| 659 | BMPR2 | C0340543 | Familial primary pulmonary hypertension | 0.409340710663245 | BEFREE;CTD_human;ORPHANET |
| 659 | BMPR2 | C0020538 | Hypertensive disease | 0.250771767132268 | BEFREE;GAD;HPO;LHGDN |
| 659 | BMPR2 | C1458155 | Mammary Neoplasms | 0.203007639249027 | BEFREE;CTD_human;LHGDN |
| 659 | BMPR2 | C0162770 | Right Ventricular Hypertrophy | 0.200549453568426 | BEFREE;HPO |
| 659 | BMPR2 | C0206081 | Hyperandrogenism | 0.200274726784213 | BEFREE;CTD_human |
| 659 | BMPR2 | C4280802 | Pulmonary venous occlusion | 0.2 | HPO |
| 659 | BMPR2 | C0039446 | Telangiectasis | 0.2 | HPO |
| 659 | BMPR2 | C0235527 | Heart Failure, Right-Sided | 0.2 | HPO |
| 659 | BMPR2 | C0340544 | Pulmonary arterial hypertension induced by drug | 0.2 | ORPHANET |
| 659 | BMPR2 | C0497247 | Increase in blood pressure | 0.2 | HPO |
| 659 | BMPR2 | C1138421 | Spider Veins | 0.2 | HPO |
| 659 | BMPR2 | C1504382 | Pulmonary artery wall hypertrophy | 0.2 | HPO |
| 659 | BMPR2 | C0013404 | Dyspnea | 0.2 | HPO |
| 659 | BMPR2 | C1867421 | Elevated right atrial pressure | 0.2 | HPO |
| 659 | BMPR2 | C1867423 | Vascular resistance pulmonary increased | 0.2 | HPO |
| 659 | BMPR2 | C1867424 | Pulmonary artery vasoconstriction | 0.2 | HPO |
| 659 | BMPR2 | C2939447 | Right ventricular failure | 0.2 | HPO |
| 659 | BMPR2 | C4025731 | Abnormal thrombosis | 0.2 | HPO |
| 659 | BMPR2 | C2973725 | Pulmonary arterial hypertension | 0.2 | HPO |
| 659 | BMPR2 | C4020753 | Intimal fibrosis | 0.2 | HPO |
| 659 | BMPR2 | C4023403 | Arterial intimal fibrosis | 0.2 | HPO |
| 659 | BMPR2 | C4025217 | Pulmonary aterial intimal fibrosis | 0.2 | HPO |
| 659 | BMPR2 | C0011853 | Diabetes Mellitus, Experimental | 0.08 | RGD |
| 659 | BMPR2 | C0152171 | Idiopathic pulmonary hypertension | 0.0079670767421799 | BEFREE |
| 659 | BMPR2 | C0039445 | Hereditary hemorrhagic telangiectasia | 0.0065647320664799 | BEFREE;LHGDN |
| 659 | BMPR2 | C0033578 | Prostatic Neoplasms | 0.0054658249296275 | LHGDN |
| 659 | BMPR2 | C0018817 | Atrial Septal Defects | 0.00300763924902685 | BEFREE;LHGDN |
| 659 | BMPR2 | C0007134 | Renal Cell Carcinoma | 0.00273291246481375 | LHGDN |
| 659 | BMPR2 | C0004096 | Asthma | 0.00273291246481375 | LHGDN |
| 659 | BMPR2 | C0020507 | Hyperplasia | 0.00273291246481375 | LHGDN |
| 659 | BMPR2 | C0013743 | Eisenmenger Complex | 0.00273291246481375 | LHGDN |
| 659 | BMPR2 | C0345893 | Juvenile polyposis syndrome | 0.0026817553075011 | BEFREE;GAD |
| 659 | BMPR2 | C1527249 | Colorectal Cancer | 0.0026817553075011 | BEFREE;GAD |
| 659 | BMPR2 | C0040961 | Tricuspid Valve Insufficiency | 0.002407028523288 | GAD |
| 659 | BMPR2 | C0040336 | Tobacco Use Disorder | 0.002407028523288 | GAD |
| 659 | BMPR2 | C0600452 | Hepatopulmonary Syndrome | 0.002407028523288 | GAD |
| 659 | BMPR2 | C0003130 | Anoxia | 0.002407028523288 | GAD |
| 659 | BMPR2 | C0023890 | Liver Cirrhosis | 0.002407028523288 | GAD |
| 659 | BMPR2 | C0007222 | Cardiovascular Diseases | 0.002407028523288 | GAD |
| 659 | BMPR2 | C3887505 | DYSFUNCTION - SKIN DISORDERS | 0.0013736339210655 | BEFREE |
| 659 | BMPR2 | C0042373 | Vascular Diseases | 0.0010989071368524 | BEFREE |
| 659 | BMPR2 | C0152021 | Congenital heart disease | 0.0010989071368524 | BEFREE |
| 659 | BMPR2 | C0340542 | Sporadic primary pulmonary hypertension | 0.0008241803526393 | BEFREE |
| 659 | BMPR2 | C0010068 | Coronary heart disease | 0.0005494535684262 | BEFREE |
| 659 | BMPR2 | C0376358 | Malignant neoplasm of prostate | 0.0005494535684262 | BEFREE |
| 659 | BMPR2 | C0600139 | Prostate carcinoma | 0.0005494535684262 | BEFREE |
| 659 | BMPR2 | C3899989 | Autosomal Dominant Disorder | 0.0005494535684262 | BEFREE |
| 659 | BMPR2 | C3887658 | PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT | 0.0005494535684262 | BEFREE |
| 659 | BMPR2 | C0009402 | Colorectal Carcinoma | 0.0005494535684262 | BEFREE |
| 659 | BMPR2 | C0015230 | Exanthema | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C1701938 | Associated Pulmonary Arterial Hypertension | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0011849 | Diabetes Mellitus | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0014060 | Encephalitis, St. Louis | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0856169 | Endothelial dysfunction | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C1402315 | Vascular lesions | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C1275685 | Avellino corneal dystrophy | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0018799 | Heart Diseases | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C1096458 | Vascular occlusion | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0679427 | myeloblastosis | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0011644 | Scleroderma | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0009782 | Connective Tissue Diseases | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C1956346 | Coronary Artery Disease | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C2363973 | Chronic thromboembolic pulmonary hypertension | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0008479 | Chondrosarcoma | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C3539781 | Progressive cGVHD | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0007113 | Rectal Carcinoma | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0007102 | Malignant tumor of colon | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0006142 | Malignant neoplasm of breast | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0005967 | Bone neoplasms | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0002873 | Anemia of chronic disease | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0019693 | HIV Infections | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0032460 | Polycystic Ovary Syndrome | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0029463 | Osteosarcoma | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0028754 | Obesity | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0085215 | Ovarian Failure, Premature | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0027627 | Neoplasm Metastasis | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0025322 | Premature Menopause | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0205734 | Diabetes, Autoimmune | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0024623 | Malignant neoplasm of stomach | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0024141 | Lupus Erythematosus, Systemic | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0279680 | Transitional cell carcinoma of bladder | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0332996 | Persistent embryonic structure | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0333186 | Restenosis | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0848332 | Spots on skin | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0019079 | Hemoptysis | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0018802 | Congestive heart failure | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0497406 | Overweight | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0555198 | Malignant Glioma | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0585442 | Osteosarcoma of bone | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0596263 | Carcinogenesis | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0018801 | Heart failure | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0677932 | Progressive Neoplastic Disease | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0678222 | Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0036421 | Systemic Scleroderma | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0699790 | Colon Carcinoma | 0.0002747267842131 | BEFREE |
| 659 | BMPR2 | C0699791 | Stomach Carcinoma | 0.0002747267842131 | BEFREE |